Article ID Journal Published Year Pages File Type
3272643 Journal de Gynécologie Obstétrique et Biologie de la Reproduction 2014 10 Pages PDF
Abstract
Review of the current literature favors the use of vaginal misoprostol 25 μg three- to six-hourly equally to dinoprostone accordingly with previous French and international guidelines (World Health Organization and American College of Obstetricians and Gynecologist). The use of misoprostol 25 μg supposes a preparation by the pharmacist to ensure the safety of this precise posology. Medico-economic studies are warranted to attest an economic benefice to the use of misoprostol 25 μg in comparison to dinoprostone.
Related Topics
Health Sciences Medicine and Dentistry Endocrinology, Diabetes and Metabolism
Authors
, ,